(Q34786835)

4 August 2017

1 reference

title

Study of cannabinoid dependence in animals (English)

1 reference

4 August 2017

0 references

Rafael Maldonado

1

1 reference

4 August 2017

publication date

1 August 2002

1 reference

Pharmacology & Therapeutics

4 August 2017

published in

1 reference

4 August 2017

volume

95

1 reference

4 August 2017

issue

2

1 reference

4 August 2017

page(s)

153-164

1 reference

Neurobiology of marijuana abuse.

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Development of behavioral tolerance to delta 9-THC without alteration of cannabinoid receptor binding or mRNA levels in whole brain

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Spontaneous and precipitated withdrawal with a synthetic cannabinoid, WIN 55212-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Tolerance to the cardiovascular effects of delta9-tetrahydrocannabinol in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Interaction of delta9-tetrahydrocannabinol and cannabidiol on intestinal motility in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Δ9-Tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Pharmacological specificity of delta 9-tetrahydrocannabinol discrimination in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Time course for the induction and maintenance of tolerance to Delta(9)-tetrahydrocannabinol in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Effects of the cannabinoid CB(1) receptor antagonist, SR141716A, after Delta(9)-tetrahydrocannabinol withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Reduction by Δ9- tetrahydrocannabinol in the blood pressure of hypertensive rats bearing regenerated adrenal glands

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Evaluation of a suspension system for intravenous self-administration studies of water-insoluble compounds in the rhesus monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

The effect of withdrawal from cannabis on pentylenetetrazol convulsive threshold in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Effects of marihuana cannabinoids on seizure activity in cobalt-epileptic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Reluctance of rats to drink hashish suspensions: free-choice and forced consumption, and the effects of hypothalamic stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Precipitated and spontaneous withdrawal in rats tolerant to anandamide

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Distribution of radioactivity in brain of tolerant and nontolerant pigeons treated with 3H-δ9-tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Mesolimbic dopaminergic decline after cannabinoid withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Opioids and rewarding brain stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Cannabinoid receptor down-regulation without alteration of the inhibitory effect of CP 55,940 on adenylyl cyclase in the cerebellum of CP 55,940-tolerant mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

delta9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Anandamides: tolerance and cross-tolerance to delta 9-tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Marijuana's interaction with brain reward systems: update 1991.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Facilitation of brain stimulation reward by delta 9-tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Different mechanisms for dopaminergic excitation induced by opiates and cannabinoids in the rat midbrain

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Evaluation of reinforcing capability of delta-9-tetrahydrocannabinol in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Morphine and delta 9-tetrahydrocannabinol: two-way cross tolerance for antinociceptive and heart-rate responses in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Tetrahydrocannabinol-attenuated abstinence and induced rotation in morphine-dependent rats: Possible involvement of dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Morphine-dependent rats: blockade of precipitated abstinence by tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Delta(9)-THC and anandamide

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with delta-9-tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Effects of lithium dose (UCS) on the acquisition and extinction of a discriminated morphine aversion: tests with morphine and delta9-THC.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Delta9-THC training dose as a determinant for (R)-methanandamide generalization in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Delta9-THC training dose as a determinant for (R)-methanandamide generalization in rats: a systematic replication.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Interaction between delta-9-tetrahydro-cannabinol and kindling by electrical and chemical stimuli in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Naloxone-induced or postwithdrawal abstinence signs in ?9-Tetrahydrocannabinol-Tolerant rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Drugs of abuse: anatomy, pharmacology and function of reward pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Drug addiction: the yin and yang of hedonic homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Effects of Delta 9-tetrahydrocannabinol, (R)-methanandamide, SR 141716,and d-amphetamine before and during daily Delta 9-tetrahydrocannabinol dosing.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Failure to obtain "cannabis-directed behavior" and abstinence syndrome in rats chronically treated with cannabis sativa extracts

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Conditioned place preference induced by delta 9-tetrahydrocannabinol: comparison with cocaine, morphine, and food reward.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Genetic differences in delta 9-tetrahydrocannabinol-induced facilitation of brain stimulation reward as measured by a rate-frequency curve-shift electrical brain stimulation paradigm in three different rat strains.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Effects of SR 141716A after acute or chronic cannabinoid administration in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Is tolerance to delta-9-THC cellular or metabolic? The subcellular distribution of delta-9-tetrahydrocannabinol and its metabolites in brains of tolerant and non-tolerant rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Delta9-tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta9-tetrahydrocannabinol or anandamide.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Failure of Delta(9)-tetrahydrocannabinol and CP 55,940 to maintain intravenous self-administration under a fixed-interval schedule in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Cannabinoid modulation of dynorphin A: correlation to cannabinoid-induced antinociception

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Electrophysiological evidence for excitation of rat ventral tegmental area dopamine neurons by morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Aversive effects of the synthetic cannabinoid CP 55,940 in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

l-delta-9-trans-tetrahydrocannabinol in pigeons: tolerance to the behavioral effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Ethanol stimulates the firing rate of nigral dopaminergic neurons in unanesthetized rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Preferential stimulation of ventral tegmental area dopaminergic neurons by nicotine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Behavioral and biochemical effects of chronic ? 9-tetrahydrocannabinol in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Drug reinforcement studied by the use of place conditioning in rat

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Molecular characterization of a peripheral receptor for cannabinoids

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

An acute dose of delta 9-tetrahydrocannabinol affects behavioral and neurochemical indices of mesolimbic dopaminergic activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Tolerance to the effect of delta1-tetrahydrocannabinol on corticosterone levels in mouse plasma produced by repeated administration of cannabis extract or delta1-tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Downregulation of rat brain cannabinoid binding sites after chronic delta 9-tetrahydrocannabinol treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to delta9-tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Autoradiographic analysis of cannabinoid receptor binding and cannabinoid agonist-stimulated [35S]GTP gamma S binding in morphine-dependent mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Antisense oligodeoxynucleotides to the kappa1 receptor enhance delta9-THC-induced antinociceptive tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Chronic CP-55,940 alters cannabinoid receptor mRNA in the rat brain: an in situ hybridization study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Loss of cannabinoid-stimulated guanosine 5'-O-(3-[(35)S]Thiotriphosphate) binding without receptor down-regulation in brain regions of anandamide-tolerant rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55,940

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Chronic delta-9-tetrahydrocannabinol treatment increases cAMP levels and cAMP-dependent protein kinase activity in some rat brain regions

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Endogenous cannabinoids as an aversive or counter-rewarding system in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Trends in place preference conditioning with a cross-indexed bibliography; 1957-1991.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Self-administration of Δ9-tetrahydrocannabinol by rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Oral and intravenous toxicity of delta9-tetrahydrocannabinol in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Evidence for a bidirectional cross-tolerance between morphine and delta 9-tetrahydrocannabinol in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Physical withdrawal in rats tolerant to delta 9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Cannabinoid withdrawal is dependent upon PKA activation in the cerebellum

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Cannabinoid withdrawal syndrome is reduced in pre-proenkephalin knock-out mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Delta9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Characterization of anandamide-induced tolerance: comparison to delta 9-THC-induced interactions with dynorphinergic systems

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Synergistic interactions of endogenous opioids and cannabinoid systems

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Chronic exposure to delta 9-tetrahydrocannabinol fails to irreversibly alter brain cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Cannabis: discrimination of "internal bliss"?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Effects of SR141716A on diazepam substitution for delta9-tetrahydrocannabinol in rat drug discrimination

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Discriminative stimulus effects of delta 9-tetrahydrocannabinol and delta 9-11-tetrahydrocannabinol in rats and rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Pharmacological specificity of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Evaluation of cannabimimetic discriminative stimulus effects of anandamide and methylated fluoroanandamide in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Evaluation of cannabimimetic effects of structural analogs of anandamide in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Behavioral Effects of Levonantradol and Nantradol in the Rhesus Monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Effects of long-term exposure to delta9-THC on expression of cannabinoid receptor (CB1) mRNA in different rat brain regions

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

Absence of delta -9-tetrahydrocannabinol dysphoric effects in dynorphin-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

(R)-methanandamide, but not anandamide, substitutes for delta 9-THC in a drug-discrimination procedure.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

THC-induced place and taste aversions in Lewis and Sprague-Dawley rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900254-1

7 January 2021

10.1016/S0163-7258(02)00254-1

Identifiers

DOI

1 reference

4 August 2017

1 reference